Gritstone bio Statistics
Total Valuation
Gritstone bio has a market cap or net worth of 147,708. The enterprise value is 46.93 million.
| Market Cap | 147,708 |
| Enterprise Value | 46.93M |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Gritstone bio has 147.71 million shares outstanding. The number of shares has increased by 17.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 147.71M |
| Shares Change (YoY) | +17.64% |
| Shares Change (QoQ) | +21.04% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 17.17% |
| Float | 145.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.35 |
| EV / Sales | 3.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.42 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 4.62.
| Current Ratio | 2.54 |
| Quick Ratio | 2.34 |
| Debt / Equity | 4.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.91 |
| Interest Coverage | -28.38 |
Financial Efficiency
Return on equity (ROE) is -201.94% and return on invested capital (ROIC) is -51.75%.
| Return on Equity (ROE) | -201.94% |
| Return on Assets (ROA) | -46.71% |
| Return on Capital (ROIC) | -51.75% |
| Revenue Per Employee | 63,247 |
| Profits Per Employee | -575,900 |
| Employee Count | 231 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.96% in the last 52 weeks. The beta is 0.76, so Gritstone bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -99.96% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 27.99 |
| Average Volume (20 Days) | 1,727,290 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.61 |
Income Statement
In the last 12 months, Gritstone bio had revenue of 14.61 million and -133.03 million in losses. Loss per share was -1.08.
| Revenue | 14.61M |
| Gross Profit | -104.94M |
| Operating Income | -136.47M |
| Pretax Income | -133.03M |
| Net Income | -133.03M |
| EBITDA | -129.23M |
| EBIT | -136.47M |
| Loss Per Share | -1.08 |
Balance Sheet
The company has 55.71 million in cash and 102.49 million in debt, giving a net cash position of -46.78 million or -0.32 per share.
| Cash & Cash Equivalents | 55.71M |
| Total Debt | 102.49M |
| Net Cash | -46.78M |
| Net Cash Per Share | -0.32 |
| Equity (Book Value) | 22.19M |
| Book Value Per Share | 0.19 |
| Working Capital | 36.81M |
Cash Flow
In the last 12 months, operating cash flow was -110.97 million and capital expenditures -1.46 million, giving a free cash flow of -112.43 million.
| Operating Cash Flow | -110.97M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | -112.43M |
| FCF Per Share | -0.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | -934.05% |
| Pretax Margin | -910.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Gritstone bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.64% |
| Shareholder Yield | -17.64% |
| Earnings Yield | -107,737.60% |
| FCF Yield | -76,117.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Gritstone bio has an Altman Z-Score of -9.03. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.03 |
| Piotroski F-Score | n/a |